Summary
The susceptibility of mice of different ages (from four to 28 days) to infection with herpes simplex virus type 1 (HSV-1) mutants inoculated onto scarified corneas was studied. The TK+ isolate from wild type virus was pathogenic in mice of all age groups. An HSV-1 mutant (designated TK1/4) with a less active thymidine kinase (TK) gene expressing 25 per cent of the TK activity of the TK+ isolate was pathogenic for mice up to 10 days of age. In older mice, virus pathogenicity was dependent on the inoculum dose: increasing the TK1/4 virus dose tenfold raised the level of TK activity and thus the virulence of the virus. A TK− mutant with no TK activity was pathogenic for four to eight day old mice that have TK activity in the brain, but not in older mice. Thus, resistance to HSV-1 that is age-dependent in mice can be determined by the extent to which the virus strain is liable to express its TK gene and by the amount of TK activity present in the brain.
This is a preview of subscription content, log in via an institution to check access.
References
Becker, Y., Shtram, Y., Snipper, D., Asher, Y., Tabor, E., Gordon, Y., Gilden, D., Wellish, M., Hadar, J., Becker, O., Cohen, A., Laban, A., Honigman, A.: The HSV-1 thymidine kinase gene controls expression in eukaryotic and prokaryotic cells and viral pathogenesis in mice. In:Shiota, H., Cheng, Y.-C., Prusoff, W. H. (eds.), Herpesvirus: Clinical, Pharmacological and Basic Aspects (Int. Congress Series 571), 57–73. Amsterdam-Oxford-Princeton: Excerpta Medica 1982.
Centifanto-Fitzgerald, Y. M., Varnell, E. D., Kaufman, H. E.: Initial herpes simplex virus type 1 infection prevents ganglionic superinfection by other strains. Infect. Immun.35, 1125–1132 (1982).
Dasgupta, U. B., Summers, W. C.: Ultraviolet reactivation of herpes simplex virus is mutagenic and inducible in mammalian cells. Proc. Natl. Acad. Sci. U.S.A.75, 2378–2381 (1978).
Elion, G. B., Furman, P. A., Fyfe, J. A., de Miranda, P., Beauchamp, L., Schaeffer, H. J.: Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl)-guanine. Proc. Natl. Acad. Sci. U.S.A.76, 5716–5720 (1979).
Field, H. J., Darby, G.: Pathogenicity in mice of strains of herpes simplex virus which are resistant to acyclovirin vitro andin vivo. Antimicrob. Agents Chemother.17, 209–216 (1980).
Field, H. J., Darby, G., Wildy, P.: Isolation and characterization of acyclovir-resistant mutants of herpes simplex virus. J. gen. Virol.49, 115–124 (1980).
Field, H. J., Wildy, P.: The pathogenicity of thymidine kinase-deficient mutants of herpes simplex virus in mice. J. Hygiene (Cambridge)81, 267–277 (1978).
Field, H. J., Wildy, P.: Recurrent herpes simplex: the outlook for systemic antiviral agents. Br. Med. J.282, 1821–1822 (1981).
Gordon, Y., Gilden, D. H., Shtram, Y., Asher, Y., Tabor, E. Wellish, M., Devlin, M., Snipper, D., Hadar, J., Becker, Y.: A low thymidine kinase-producing mutant of herpes simplex virus type 1 causes latent trigeminal ganglia infections in mice. Arch. Virol.76, 39–49 (1983).
Klein, R. J., Friedman-Kien, A. E., Destefano, E.: Pathogenesis of experimental skin infections induced by drug-resistant herpes simplex virus mutants. Infec. Immun.34, 693–701 (1981).
Kohl, S., Loo, L. S.: Protection of neonatal mice against herpes simplex infection: probablyin vivo antibody-dependent cellular cytotoxicity. J. Immunol.129, 370–376 (1982).
Marcialis, M. A., la Colla, P., Schivo, M. L., Flore, O., Firinu, A., Loddo, B.: Low virulence and immunogenicity in mice and in rabbits of variants of herpes simplex virus resistant to 5-iodo-2-deoxyuridine. Experientia31, 502–503 (1975).
Pavan-Langston, D., Park, N. H., Lass, J. H.: Herpetic ganglionic latency. Acyclovir and vidarabine therapy. Arch. Ophthalmol.97, 1508–1510 (1979).
Price, R. W., Kahn, A.: Resistance of peripheral autonomic neurons toin-vivo productive infection by herpes simplex virus mutants deficient of TK activity. Infec. Immun.34, 571–580 (1981).
Schnipper, L. E., Crumpacker, C. S.: Resistance of herpes simplex virus to acycloguanosine: role of viral thymidine kinase and DNA polymerase loci. Proc. Natl. Acad. Sci. U.S.A.77, 2270–2273 (1980).
Schröder, C. H., Engler, H., Kirchner, H.: Protection of mice by an apathogenic strain of HSV-1 against lethal infection by a pathogenic strain of HSV-1. J. gen. Virol.52, 159–161 (1981).
Sung, S. C.: Thymidine kinase in the developing rat brain. Brain Res.35, 268–271 (1971).
Tenser, R. B., Dunstan, M. E.: Herpes simplex virus thymidine kinase expression in infection of the trigeminal ganglion. Virology99, 417–422 (1979).
Tenser, R. B., Miller, R. L., Rapp, F.: Trigeminal ganglion infection by thymidine kinase-negative mutants of herpes simplex virus. Science205, 915–917 (1979).
Tenser, R. B., Ressel, S., Dunstan, M. E.: Herpes simplex virus thymidine kinase expression in trigeminal ganglion infection: correlation of enzyme activity with ganglion virus titer and evidence ofin vivo complementation. Virology112, 328–341 (1981).
Weichsel, M. E. Jr.: Effect of thyroxine on DNA synthesis and thymidine kinase activity during cerebellar development. Brain Res.78, 455–465 (1974).
Yamagami, S., Mori, K. Kawakita, Y.: Changes of thymidine kinase in the developing rat brain. J. Neurochem.19, 369–376 (1972).
Zawatzky, R., Engler, H., Kirchner, H.: Experimental infection of inbred mice with herpes simplex virus. III. Comparison between newborn and adult C 57 BL/6 mice. J. gen. Virol.60, 25–29 (1982).
Author information
Authors and Affiliations
Additional information
With 1 Figure
Rights and permissions
About this article
Cite this article
Ben-Hur, T., Hadar, J., Shtram, Y. et al. Neurovirulence of herpes simplex virus type 1 depends on age in mice and thymidine kinase expression. Archives of Virology 78, 303–308 (1983). https://doi.org/10.1007/BF01311326
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01311326